Multiple Myeloma | Proceedings from a live event held in conjunction with the 2021 Pan Pacific Lymphoma Conference

Featuring perspectives from Drs Muhamed Baljevic, Joseph Mikhael and Nina Shah, moderated by Dr Robert Orlowski: Introduction (0:00) Up-Front Management of Newly Diagnosed Multiple Myeloma — Robert Z Orlowski, MD, PhD Selection and Sequencing of Therapies for Patients with Relapsed/Refractory Multiple Myeloma — Joseph Mikhael, MD (32:36) CAR (Chimeric Antigen Receptor) T-Cell Therapy for Relapsed/Refractory Multiple Myeloma — Nina Shah, MD (50:28) Novel Agents and Strategies Under Investigation in Multiple Myeloma — Muhamed Baljevic, MD (1:10:11) CME information and select publications